| |
| |
|
| Insider
Information: |
Breitmeyer James B |
| Relationship: |
Chief Executive Office... |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
453,034 |
|
|
Indirect Shares
|
212,703 |
|
|
| Direct
Value |
$151,783 |
|
|
|
Indirect Value
|
$72,872 |
|
|
| Total
Shares |
665,737 |
|
|
| Total
Value |
$224,655 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
3
|
0
|
|
Stock
price went up :
|
2
|
0
|
| Stock
price went down : |
1
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
2.0
|
0.0
|
| Percentage
Gain/Loss : |
 43.5%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Cadence Pharmaceuticals Inc |
CADX |
EVP, CMO |
2011-11-03 |
10,000 |
2009-09-01 |
0 |
Premium* |
|
|
Zogenix, Inc. |
ZGNX |
Director |
2022-03-07 |
0 |
|
0 |
Premium* |
|
|
Oncternal Therapeutics Inc |
ONCT |
Chief Executive Office... |
2024-01-03 |
443,034 |
2024-01-03 |
212,703 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
54 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ZGNX |
Zogenix, Inc. |
Director |
– • – |
2014-03-25 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
10,000 |
|
- |
|
| CADX |
Cadence Pharmaceuticals I... |
EVP, CMO |
• – – |
2008-02-20 |
4 |
A |
$5.34 |
$53,400 |
D/D |
10,000 |
10,000 |
0 |
- |
|
| CADX |
Cadence Pharmaceuticals I... |
EVP, CMO |
• – – |
2009-09-01 |
4 |
OE |
$3.20 |
$3,200 |
D/D |
1,000 |
11,000 |
0 |
- |
|
| CADX |
Cadence Pharmaceuticals I... |
EVP, CMO |
• – – |
2009-09-01 |
4 |
AS |
$10.81 |
$10,810 |
D/D |
(1,000) |
10,000 |
0 |
- |
|
| CADX |
Cadence Pharmaceuticals I... |
EVP, CMO |
• – – |
2009-10-01 |
4 |
OE |
$3.20 |
$3,200 |
D/D |
1,000 |
11,000 |
0 |
- |
|
| CADX |
Cadence Pharmaceuticals I... |
EVP, CMO |
• – – |
2009-10-01 |
4 |
AS |
$10.96 |
$10,960 |
D/D |
(1,000) |
10,000 |
0 |
- |
|
| CADX |
Cadence Pharmaceuticals I... |
EVP, CMO |
• – – |
2009-11-05 |
4 |
AS |
$10.00 |
$10,000 |
D/D |
(1,000) |
10,000 |
0 |
- |
|
| CADX |
Cadence Pharmaceuticals I... |
EVP, CMO |
• – – |
2009-11-05 |
4 |
OE |
$3.20 |
$3,200 |
D/D |
1,000 |
11,000 |
0 |
- |
|
| CADX |
Cadence Pharmaceuticals I... |
EVP, CMO |
• – – |
2009-12-17 |
4 |
OE |
$3.20 |
$3,200 |
D/D |
1,000 |
11,000 |
0 |
- |
|
| CADX |
Cadence Pharmaceuticals I... |
EVP, CMO |
• – – |
2009-12-17 |
4 |
AS |
$10.00 |
$10,000 |
D/D |
(1,000) |
10,000 |
0 |
- |
|
| CADX |
Cadence Pharmaceuticals I... |
EVP, CMO |
• – – |
2010-01-05 |
4 |
OE |
$3.20 |
$3,200 |
D/D |
1,000 |
11,000 |
0 |
- |
|
| CADX |
Cadence Pharmaceuticals I... |
EVP, CMO |
• – – |
2010-01-05 |
4 |
AS |
$10.00 |
$10,000 |
D/D |
(1,000) |
10,000 |
0 |
- |
|
| CADX |
Cadence Pharmaceuticals I... |
EVP, CMO |
• – – |
2010-02-01 |
4 |
AS |
$10.00 |
$10,000 |
D/D |
(1,000) |
10,000 |
0 |
- |
|
| CADX |
Cadence Pharmaceuticals I... |
EVP, CMO |
• – – |
2010-02-01 |
4 |
OE |
$3.20 |
$3,200 |
D/D |
1,000 |
11,000 |
0 |
- |
|
| CADX |
Cadence Pharmaceuticals I... |
EVP, CMO |
• – – |
2010-04-19 |
4 |
OE |
$3.20 |
$3,200 |
D/D |
1,000 |
11,000 |
0 |
- |
|
| CADX |
Cadence Pharmaceuticals I... |
EVP, CMO |
• – – |
2010-04-19 |
4 |
AS |
$10.00 |
$10,000 |
D/D |
(1,000) |
10,000 |
0 |
- |
|
| CADX |
Cadence Pharmaceuticals I... |
EVP, CMO |
• – – |
2010-09-27 |
4 |
OE |
$3.20 |
$7,562 |
D/D |
2,363 |
12,363 |
0 |
- |
|
| CADX |
Cadence Pharmaceuticals I... |
EVP, CMO |
• – – |
2010-09-27 |
4 |
AS |
$8.50 |
$20,086 |
D/D |
(2,363) |
10,000 |
0 |
- |
|
| CADX |
Cadence Pharmaceuticals I... |
EVP, CMO |
• – – |
2010-09-29 |
4 |
OE |
$3.20 |
$14,838 |
D/D |
4,637 |
14,637 |
0 |
- |
|
| CADX |
Cadence Pharmaceuticals I... |
EVP, CMO |
• – – |
2010-09-29 |
4 |
AS |
$8.50 |
$39,415 |
D/D |
(4,637) |
10,000 |
0 |
- |
|
| CADX |
Cadence Pharmaceuticals I... |
EVP, CMO |
• – – |
2010-10-05 |
4 |
AS |
$8.50 |
$59,500 |
D/D |
(7,000) |
10,000 |
0 |
- |
|
| CADX |
Cadence Pharmaceuticals I... |
EVP, CMO |
• – – |
2010-10-05 |
4 |
OE |
$3.20 |
$22,400 |
D/D |
7,000 |
17,000 |
0 |
- |
|
| CADX |
Cadence Pharmaceuticals I... |
EVP, CMO |
• – – |
2010-11-01 |
4 |
OE |
$3.20 |
$22,400 |
D/D |
7,000 |
17,000 |
0 |
- |
|
| CADX |
Cadence Pharmaceuticals I... |
EVP, CMO |
• – – |
2010-11-01 |
4 |
AS |
$9.00 |
$63,000 |
D/D |
(7,000) |
10,000 |
0 |
- |
|
| CADX |
Cadence Pharmaceuticals I... |
EVP, CMO |
• – – |
2010-11-02 |
4 |
OE |
$3.20 |
$57,600 |
D/D |
18,000 |
28,000 |
0 |
- |
|
54 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
